Kush Parmar
Director, Audentes Therapeutics, Inc.
Companies
- Entrada Therapeutics, Inc.Board member Oct 28, 2021 to now1
- RallybioBoard member Jul 29, 2021 to May 17, 20242
- Akouos, Inc.Board member Jun 25, 2020 to Dec 2, 20223
- Q32 Bio Inc.Board member Mar 27, 2018 to Jun 17, 20224
- Vor Biopharma Inc.Board member Feb 4, 2021 to Jun 16, 20225
- 5:01 Acquisition Corp.Board member Oct 13, 2020 to Dec 1, 20206
- 5:01 Acquisition Corp.Chief executive officer Oct 13, 2020 to Dec 1, 20206
- Arvinas (United States)Board member Sep 26, 2018 to Sep 26, 20197
- scPharmaceuticals (United States)Board member Nov 16, 2017 to Jun 21, 20188
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vor Biopharma Inc. VOR1,766,634 shares9$34.1M at $19.30Nov 16, 2021
Rallybio RLYB1,251,755 shares10$20.9M at $16.70Mar 9, 2023- Entrada Therapeutics, Inc. TRDA1,093,313 shares11$5.4M at $4.92Aug 10, 2026
- Akouos, Inc.0 shares12Nov 30, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2026Sold 1,285 shares at $1.91 of Skye Bioscience, Inc.13
- Sep 16, 2026Sold 32,607 shares at $1.91 of Skye Bioscience, Inc.13
- Aug 10, 2026Sold 92,444 shares at $7.00 of Entrada Therapeutics, Inc.11
- Aug 7, 2026Sold 52,317 shares at $6.85 of Entrada Therapeutics, Inc.11
- Aug 6, 2026Sold 10,494 shares at $7.00 of Entrada Therapeutics, Inc.11
- Jul 31, 2026Sold 1,718 shares at $6.85 of Entrada Therapeutics, Inc.14
- Jul 30, 2026Sold 114,756 shares at $6.93 of Entrada Therapeutics, Inc.14
- Nov 14, 2025Sold 200,000 shares at $8.80 of Entrada Therapeutics, Inc.15
- Jul 9, 2025Sold 6,935 shares at $7.50 of Entrada Therapeutics, Inc.16
- Jul 9, 2025Sold 20,065 shares at $7.50 of Entrada Therapeutics, Inc.16
- Jul 1, 2025Sold 6,422 shares at $7.12 of Entrada Therapeutics, Inc.17
- Jul 1, 2025Sold 18,578 shares at $7.12 of Entrada Therapeutics, Inc.17
- Jun 30, 2025Sold 6,422 shares at $6.81 of Entrada Therapeutics, Inc.17
- Jun 30, 2025Sold 18,578 shares at $6.81 of Entrada Therapeutics, Inc.17
- Jun 27, 2025Sold 19,265 shares at $6.91 of Entrada Therapeutics, Inc.17
- Jun 27, 2025Sold 55,735 shares at $6.91 of Entrada Therapeutics, Inc.17
- Mar 13, 2024Bought 450,000 shares at $10.00 of Skye Bioscience, Inc.18
- Mar 7, 2023Sold 100,000 shares at $8.20 of Rallybio10
- Nov 30, 2022U 982,453 shares of Akouos, Inc.12
- Nov 30, 2022U 3,153,333 shares of Akouos, Inc.12
- Jun 3, 2022Sold 50,329 shares at $12.50 of Rallybio19
- Jun 3, 2022Sold 99,671 shares at $12.50 of Rallybio19
- May 23, 2022Sold 33,553 shares at $13.00 of Rallybio20
- May 23, 2022Sold 66,447 shares at $13.00 of Rallybio20
- Feb 8, 2022Sold 70,461 shares at $13.05 of Rallybio21
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARRallybio, Board member
- 3SEC EDGARAkouos, Inc., Board member
- 4SEC EDGARQ32 Bio Inc., Board member
- 5SEC EDGARVor Biopharma Inc., Board member
- 6SEC EDGAR5:01 Acquisition Corp., Board member
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARForm 4 filed Sep 18, 2026
- 14SEC EDGARForm 4 filed Aug 3, 2026
- 15SEC EDGARForm 4 filed Nov 18, 2025
- 16SEC EDGARForm 4 filed Jul 11, 2025
- 17SEC EDGARForm 4 filed Jul 1, 2025
- 18SEC EDGARForm 4 filed Mar 15, 2024
- 19SEC EDGARForm 4 filed Jun 7, 2022
- 20SEC EDGARForm 4 filed May 25, 2022
- 21SEC EDGARForm 4 filed Feb 10, 2022